Company newsForm 8-K and release

Bruker BRKR

Bruker appoints Eicke Latz to its board, effective January 1, 2027

The board also declared a quarterly cash dividend of $0.05 per share, payable January 7, 2027.

GetSignal 

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

On November 13, 2026, Bruker's board approved adding one seat, bringing the board to twelve directors, and appointed Eicke Latz, MD PhD, to fill the new seat, effective January 1, 2027. Bruker said Latz will initially serve as a director until the 2029 Annual Meeting of Stockholders, in Class II.

Bruker said Latz's director compensation will be consistent with that of its other non-employee directors, as described in its 2026 proxy statement. Bruker said it will file an amended Form 8-K to disclose his committee assignments once they are determined.

Chairman, President and CEO Frank H. Laukien said Latz's disease biology leadership, biopharma experience and medical institute leadership would be valuable to the board as Bruker expands its work in post-genomic life-science tools, molecular diagnostics and drug discovery.

Latz is Scientific Director of the German Rheumatology Research Center and Professor of Experimental Rheumatology at Charité Universitätsmedizin Berlin. He has co-founded five biotechnology companies, including IFM Therapeutics, Odyssey Therapeutics, Metaimmune Therapeutics, DiosCure Therapeutics and Beren Therapeutics.

On November 12, 2026, the board declared a quarterly cash dividend of $0.05 per share on Bruker's common stock, payable January 7, 2027, to shareholders of record at the close of business on December 21, 2026.

Key facts

Effective
January 1, 2027
Board size
Twelve directors
Initial term ends
2029 Annual Meeting of Stockholders
Quarterly dividend
$0.05 per share
Dividend record date
December 21, 2026
Dividend payable
January 7, 2027

All BRKR news

Sources: Form 8-K filed November 16, 2026, and the company's release on Business Wire, November 16, 2026.

Written by GetSignal with AI from the company's press release. How we make news

Not investment advice.

More company news

Bruker first, then the newest
  1. Medtronic says it intends to acquire Contego Medical

    MDT · Medtronic · Company release · Nov 16, 2026

All company news